Information:
Fel:
ID
29021
Beskrivning
Study part: Data Verification (Month 24). A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Nyckelord
Versioner (1)
- 2018-02-20 2018-02-20 -
Rättsinnehavare
Roche
Uppladdad den
20 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Data Verification (Month 24) rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Data Verification (Month 24)
- StudyEvent: ODM
Similar models
Data Verification (Month 24)
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
Data Verification
Item
I have reviewed the case report forms and find the data to be complete and accurate.
boolean
C4086865 (UMLS CUI [1])
Investigator
Item
Investigator
text
C2346576 (UMLS CUI [1])
Date
Item
Date:
date
C0011008 (UMLS CUI [1])